��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2005, 31(1) 21-23 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	Ƥ��
	��
	ҩ��Ʒ�
	��
	��տ�
	��
	PubMed
	Article by
	Article by

Ƥ��Դ��ķ��ƺ��

��տ�, ��

��е��ҽԺƤ�� 310009

ժҪ��

��Ƥ����һ��֢״��Ŀǰ��ľ��в�ʮ��ͨ��ʹ�õĿ��鰷ҩ��һ��ֻ��ЧǷ�ѡ��о��ֳ��鰷�⻹�ж��ֽ��ʲ��γ�,��Ӧ��Ҳ��չ�˶��µ��ҩ�Ｐ��ֶΡ�

�ؼ���� Ƥ�� ҩ��Ʒ�

Abstract:

Keywords:

�ո�� 2004-03-12 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Twycross R, Greaves MW, Handwerker H, et al. Itch:scratching more than the surface. QJM, 2003, 96:7-26.
[2] Schmelz M, Schmidt R, Bickel A, et al. Specific C-receptors for itch in human skin. J Neurosci, 1997, 17:8003-8008.
[3] Andrew D, Craig AD. Spinothalamic lamina I neurons selectively sensitive to histamine:a central neural pathway for itch. Nat Neurosci,2001,4:72-77.
[4] Darsow U, Drzezga A, Frisch M, et al. Processing of histamine-induced itch in the human cerebral cortex:a correlation analysis with dermal reactions. J Invest Dermatol, 2000, 115:1029-1033.
[5] Stander S, Steinhoff M, Schmelz M, et al. Neurophysiology of pruritus:cutaneous elicitation of itch. Arch Dermatol, 2003, 139:1463-1470.
[6] Miyamoto T, Nojima H, Kuraishi Y. Intradermal cholinergic agonists induce itch-associated response via M3 muscarinic acetylcholine receptors in mice. Jpn J Pharmacol, 2002, 88:351-354.
[7] Steinhoff M, Neisius U, Ikoma A, et al. Proteinase-activated receptor-2 mediates itch:a novel pathway for pruritus in human skin. J Neurosci, 2003, 23:6176-6180.
[8] Neisius U, Olsson R, Rukwied R, et al. Prostaglandin E2 induces vasodilation and pruritus, but no protein extravasation in atopic dermatitis and controls. J Am Acad Dermatol, 2002, 47:28-32.
[9] Johansson O, Liang Y, Emtestam L. Increased nerve growth factorand tyrosine kinase A-like immunoreactivities in prurigo nodularis skin-an exploration of the cause of neurohyperplasia. Arch Dermatol Res,2002, 293:614-619.
[10] Grewe M, Vogelsang K, Ruzicka T, et al. Neurotrophin-4 production by human epidermal keratinocytes:increased expression in atopic dermatitis. J Invest Dermatol, 2000, 114:1108-1112.
[11] Yosipovitch G, Fleischer A. Itch associated with skin disease:advances in pathophysiology and emerging therapies. Am J Clin Derma tol, 2003, 4:617-622.
[12] Drake LA, Fallon JD, Sober A. Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group. J Am Acad Dermatol, 1994, 31:613-616.
[13] Weisshaar E, Kucenic MJ, Fleischer AB Jr. Pruritus:a review. Acta Derm Venereol Suppl (Stockh), 2003, (213) :5-32.
[14] Miller MJ, Vergnolle N, McKnight W, et al. Inhibition of neurogenic inflammation by the Amazonian herbal medicine sangre de grado. J Invest Dermatol, 2001, 117 i725-730.
[15] Yosipovitch G, Sugeng MW, Chan YH, et al. The effect of topically applied aspirin on localized circumscribed neurodermatitis. J Am Acad Dermatol, 2001,45:910-913.
[16] Freitag G, Hoppner T. Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Curr Med Res Opin, 1997, 13:529-537.
[17] Fleischer AB Jr. Treatment of atopic dermatitis:role of tacrolimus ointment as a topical noncorticosteroidal therapy. J Allergy Clin lmmunol, 1999, 104:S126-S130.
[18] Metze D, Reimann S, Beissert S,et al. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol, 1999,41:533-539.
[19] Cather JC, Abramovits W, Menter A. Cyclosporine and tacrolimus in dermatology. Dermatol Clin, 2001, 19:119-137.
[20] Wallengren J, Sundler F. Cutaneous field stimulation in the treatment of severe itch. Arch Dermatol, 2001, 137:1323-1325.

��е��

1��þ�,��Ⱥ,��.Koebner��о��չ[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 213-

2��Ҷ��,��,.��ư��쳣�ǻ��Ƥ��[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 205-

3��˼,��Ծ��.��Ѫ�Ѳ�A��ĳЩƤ��Ĺ�ϵ[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 211-

4��Ԭ��ϼ,��.��ϸ����Ӽ��ĳЩƤ��Ĺ�ϵ[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 225-

5��.�ֲ��Ī˾��Ƥ��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(1): 59-

6��,��ɽ�.��غ�Ƥ��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(1): 48-

7��,�浤.��ϸ��ƶ��Ƥ��Ե��о��չ[J]. ��Ƥ��Բ�ѧ��־, 2006,32(2): 127-

8��º�,�ｨ��.ɳ��Ȱ��Ƥ��Ľ�չ[J]. ��Ƥ��Բ�ѧ��־, 2006,32(2): 105-

9��Ȼ,��.��Ƥ��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(2): 111-

10��˳�ӱ,��,֣־��.��׻��оƬ��Ƥ��о��е�Ӧ��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(2): 121-

11��Ǯ��,��ǧ��,�Ź��.��͡��ҩ��Ƥ��Ƶ�Ӧ��չ��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(3): 139-